Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. - Wikidata - awgldk - TriplyDB

Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.

Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.

http://www.wikidata.org/entity/Q52578077

about

The role of sphingosine-1-phosphate in endothelial barrier function Activation of RhoA, but Not Rac1, Mediates Early Stages of S1P-Induced Endothelial Barrier Enhancement Morphine for the treatment of pain in sickle cell disease Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeability In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury.Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitors Paxillin mediates stretch-induced Rho signaling and endothelial permeability via assembly of paxillin-p42/44MAPK-GEF-H1 complex.Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome.Increased μ-opioid receptor expression in metastatic lung cancer Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer.Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung.Regulation of neutrophilic inflammation by proteinase-activated receptor 1 during bacterial pulmonary infection.Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection.Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation Morphine use in cancer surgery Knock out of S1P3 receptor signaling attenuates inflammation and fibrosis in bleomycin-induced lung injury mice model.Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs.Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.Hyaluronan regulation of vascular integrity Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules Extracellular Vesicles from Caveolin-Enriched Microdomains Regulate Hyaluronan-Mediated Sustained Vascular Integrity.Effect of mu Agonists on Long-Term Survival and Recurrence in Nonsmall Cell Lung Cancer Patients.Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality Regulation of vascular permeability by sphingosine 1-phosphate.Activated protein C in sepsis: the promise of nonanticoagulant activated protein C.Sphingosine-1-phosphate receptor 3 influences cell cycle progression in muscle satellite cells.Vascular and dendritic cell coagulation signaling in sepsis progression.Sphingosine 1-phosphate in coagulation and inflammation.The roles of thrombin and protease-activated receptors in inflammation.Endothelium--role in regulation of coagulation and inflammation.Barrier enhancing signals in pulmonary edema.Regional anaesthesia and cancer metastases: the implication of local anaesthetics.Impact of anesthesia for cancer surgery: Continuing professional development.Endothelial nanomedicine for the treatment of pulmonary disease.Endothelial barrier dysfunction in septic shock.The mu opioid receptor: A new target for cancer therapy?Sphingosine-1-Phosphate Signaling in Endothelial Disorders.

P2860

Q26862336-30FD4132-610C-4DC3-889A-9D94C49B1DD2 Q27346879-900B259E-BE86-4CC5-A649-2E9024A54DCE Q28087296-79D76146-3767-4773-98C3-1DDE4A6471A9 Q28478866-1EAEAD32-21D3-44C4-B059-C19358427249 Q28482145-79365296-AF25-4868-8B8D-4A5DF856493A Q30423883-234FB960-C3E5-44E2-B292-275B31C56A85 Q33702325-9101F3E5-9AED-4F10-AABE-6666D4AAC66A Q33775159-769F739C-607D-4330-A0AB-CE10793DD7FF Q33816773-31D30200-6E26-4156-AAFB-2D325734B489 Q33951500-0ADE0923-6E0E-4979-9DFE-AB4617B38ECB Q33951506-9C6D4B28-B822-4A92-9AF4-F0140104BC9D Q34184813-006B72BF-228F-409E-BCFB-561F2EF1CC6A Q34475362-A7F00BBC-B33B-4C33-97AD-BDF8248F123A Q34707273-1719384D-BA1C-4D3D-A83E-A887EA015D33 Q35011905-E0CCB458-8C74-4374-9D5A-C228DD70FE5F Q35083162-9109CF57-6FB3-4222-98BB-BD0F11B9D574 Q35151843-59CD34E0-FE14-4553-9B01-49BE42BBE2C3 Q35242288-0B5B6F1B-65D3-4401-9D82-1BBE32DE2F6E Q35325265-BF92652B-DAE7-4499-AE60-2B8CDE42E456 Q35551835-F3325F59-D16C-4657-ADF8-4375FAF35F6B Q35660196-ABC2AA46-A941-4B0A-80A5-ED2187A9B5B8 Q35684358-37C979BB-CAAE-4BDA-86A2-1F1AF174D241 Q36089279-B02AFC19-9794-4FAE-A56D-C1D46F138361 Q36194004-F6DE96E2-A7AE-44E3-9D8F-5B0B8D71D9E5 Q36539650-FE2E16C0-2025-492B-A360-428225047515 Q37142196-4BFC55D2-EFE6-4397-B131-3B40F2E0E556 Q37219703-12C7F90E-5C9F-4980-8250-5422FF504442 Q37241529-3EED9D17-49E4-41E0-8388-43A1A1475C1D Q37504736-3AA858E5-CF92-4992-A72E-06C7F1AA328C Q37561489-12A143B5-A495-47F3-86E2-4E9037A74012 Q37909176-09EA15ED-10F4-487C-9DDA-A1F9F7FE4CE5 Q37910045-D40BEB3A-2BD1-4A0F-B950-9424E2B6938B Q37918456-4D6A0DCC-873B-40A2-BA98-34572232F5B5 Q38110515-6897627B-93FD-42D0-859B-BFD834899363 Q38153450-A7D7C487-4FB8-45E9-B06B-34C41A001EEA Q38156029-389A8D09-1A71-4B52-9281-498E4C4899E9 Q38267984-21B6F8E2-50FA-45AC-91C8-AEB9698D52C3 Q38270705-9423AB79-3BF1-4074-96E6-7903D55D49D9 Q38515846-3113729B-6405-483A-B048-9A72C68FC627 Q38817761-6E818F84-8D2E-45D2-8B7B-6F425DF50A63

P2860

Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.

http://www.wikidata.org/entity/Q52578077

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Attenuation of vascular permea ...... OP-R and S1P3 transactivation.

@en

Attenuation of vascular permea ...... OP-R and S1P3 transactivation.

@nl

type

label

Attenuation of vascular permea ...... OP-R and S1P3 transactivation.

@en

Attenuation of vascular permea ...... OP-R and S1P3 transactivation.

@nl

prefLabel

Attenuation of vascular permea ...... OP-R and S1P3 transactivation.

@en

Attenuation of vascular permea ...... OP-R and S1P3 transactivation.

@nl

P1433

Q52578077-7E9D9F65-E80D-43D8-916D-FD0CD00E1843

P1476

Q52578077-8017BFAF-599D-4F32-ABA6-0A73C5FC52E1

P2093

Q52578077-083DD36D-B611-496F-AE03-1EB9D74102A0

Q52578077-0EB1506B-36E0-4D98-B4BB-B5B733A14820

Q52578077-2E894D7B-8E07-4E74-82A2-DFBBB9ED91FA

Q52578077-37C4491B-EF5E-41B1-9C7D-F2DF38E46AB8

Q52578077-72B641CC-68C6-4845-811B-3EC3CB2D221B

Q52578077-CDAF0F16-2123-473F-955D-219C6613B5F2

P2860

Q52578077-0B3B0D43-1618-4E03-8D6F-B6C30488F845

Q52578077-0FFF6F49-AAF3-4CBB-8F06-9FE90C73BF60

Q52578077-10DF381B-6206-4192-9490-12BEC659BC4A

Q52578077-189F7767-3709-4FE1-9E23-E0E8D765C47A

Q52578077-1D13479C-AF71-4D95-B444-9276C73A0CAD

Q52578077-1F412B93-3BA5-4E05-AD71-E5D9C8FF1C28

Q52578077-28F428B8-0D61-43E4-B462-AC53E0627497

Q52578077-2D14999E-E085-489F-B01C-6538DF3F00CF

Q52578077-3270D73B-F9A1-497E-AD95-FD8DE1F05FA3

Q52578077-32A3DCE4-4129-4F29-953D-EA2A42351D08

P304

Q52578077-E427F034-7453-46EA-850B-E054195F28D0

P31

Q52578077-04009DFE-ADBD-4CAB-8A85-89592071A0BC

P356

Q52578077-002EF599-AAFD-414E-874C-5E22736C6803

P433

Q52578077-94066047-E890-4885-B84F-CF5C5D771878

P478

Q52578077-9D743CEE-2C89-4BB5-88D0-9E6C02DB1C40

P577

Q52578077-24D2C9B9-0312-4F16-9B3A-5CB3969D3AE1

P698

Q52578077-625B856F-528D-4028-AB49-5C7FFA6013AC

P356

RCMB.2006-0327OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Attenuation of vascular permea ...... OP-R and S1P3 transactivation.

@en

P2093

Joe G N Garcia

http://www.w3.org/2001/XMLSchema#string

Jonathan Moss

http://www.w3.org/2001/XMLSchema#string

Liliana Moreno-Vinasco

http://www.w3.org/2001/XMLSchema#string

Patrick A Singleton

http://www.w3.org/2001/XMLSchema#string

Saad Sammani

http://www.w3.org/2001/XMLSchema#string

Sherry L Wanderling

http://www.w3.org/2001/XMLSchema#string

P2860

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine

Sphingosine-1-phosphate: an enigmatic signalling lipid

S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF.

Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro

Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors.

Thrombin and phenotypic modulation of the endothelium.

Opioid agonist-antagonist drugs in acute and chronic pain states.

Sphingosine 1-phosphate as a therapeutic agent.

Endothelial cell barrier regulation by sphingosine 1-phosphate.

P304

222-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2006-0327OC

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17395891

http://www.w3.org/2001/XMLSchema#string